Epilepsy in Neurological Phenotypes of Epidermal Nevus Syndrome

Abstract

Epidermal nevus syndrome (ENS) encompasses a group of congenital genetic disorders characterized by the association of an epidermal nevus with systemic anomalies including the brain. The most frequent subtype with neurological features is linear sebaceous nevus syndrome (LSNS), followed by keratinocytic nevus syndrome (ENS). Both are caused by postzygotic RAS mutations. All forms of ENS are mosaic disorders that share a common embryological basis and pathogenesis as neurocristopathies. The lines of Blaschko indicate the cutaneous migratory pathways of neural crest. Neural crest defects explain the development of nevi and associated multisystemic anomalies: brain, ocular, osseous, muscular, orodental, cardiovascular, endocrine, renal/urinary, and adipose tissue. Epilepsy and cognitive and motor deficits are caused mainly by hemimegalencephaly (HME), a closely related mosaic anomaly caused by somatic mutations in PI3K–AKT3–mTOR pathway that determines overgrowth. The usual onset of epilepsy is in the neonatal period or early infancy, often as infantile spasms. The pioneer description of nevus sebaceous in 1895 by Jadassohn is the basis for delineating the LSNS. The eponym “Schimmelpenning syndrome” as a substitute for that long-established term makes no sense in the context of the large number of authors who contributed to defining this syndrome. A review of 111 cases of LSNS and other subtypes enabled a classification of neurological phenotypes; epilepsy occurred in 77% and HME in 38%. Three distinctive additional syndromes also are within the spectrum of ENS: CLOVES, SCALP, and Heide's syndrome. The impact of epilepsy in patients affected by ENS is related to time of onset and extent of brain anomalies. Timing of the mutation determines the phenotype and severity of the systemic lesions.

Keywords

hemimegalencephaly - neurocristopathy - keratinocytic nevus syndrome - linear sebaceous nevus syndrome - CLOVES syndrome - Heide's syndrome - congenital hemifacial hyperplasia with lipomatosis - timing

• References

• 1 Solomon LM, Fretzin DF, Dewald RL. The epidermal nevus syndrome. Arch Dermatol 1968; 97 (3) 273-285
• 2 Solomon LM, Esterly NB. Epidermal and other congenital organic nevi. Curr Probl Pediatr 1975; 6: 1-56
• 3 Marden PM, Venters Jr HD. A new neurocutaneous syndrome. Am J Dis Child 1966; 112 (1) 79-81
• 4 Rogers M, McCrossin I, Commens C. Epidermal nevi and the epidermal nevus syndrome. A review of 131 cases. J Am Acad Dermatol 1989; 20 (3) 476-488
• 5 Sugarman JL. Epidermal nevus syndromes. Semin Cutan Med Surg 2007; 26 (4) 221-230
• 6 Sugarman GI, Reed WB. Two unusual neurocutaneous disorders with facial cutaneous signs. Arch Neurol 1969; 21 (3) 242-247
• 7 Wauschkuhn J, Rohde B. Systematized sebaceous, pigmented and epithelial nevi with neurologic symptoms. Neuroectodermal Feuerstein-Mims syndrome [in German]. Hautarzt 1971; 22 (1) 10-13
• 8 Lansky LL, Funderburk S, Cuppage FE, Schimke RN, Diehl AM. Linear sebaceous nevus syndrome. A hamartoma variant. Am J Dis Child 1972; 123 (6) 587-590
• 9 Holden KR, Dekaban AS. Neurological involvement in nevus unis lateris and nevus linearis sebaceus. Neurology 1972; 22 (9) 879-887
• 10 Carlier G, Lambotte C, Pierard G. [The diversities of phacomatosis (hamartosis). Apropos of a case likely to represent a new syndrome [in French]. Arch Fr Pediatr 1974; 31 (7) 657-668
• 11 Hornstein OP, Knickenberg M. On the Schimmelpenning-Feuerstein-Mims-syndrome (organoid nevus-phakomatosis) [author's transl; in German]. Arch Dermatol Forsch 1974; 250 (1) 35-50
• 12 Carey DE, Drezner MK, Hamdan JA , et al. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia. J Pediatr 1986; 109 (6) 994-1000
• 13 Eichler C, Flowers FP, Ross J. Epidermal nevus syndrome: case report and review of clinical manifestations. Pediatr Dermatol 1989; 6 (4) 316-320
• 14 David P, Elia M, Garcovich A, Colosimo Jr C, Tagliaferri G, Macchi G. A case of epidermal nevus syndrome with carotid malformation. Ital J Neurol Sci 1990; 11 (3) 293-296
• 15 Tokatli A, Coşkun T, Özalp I. Hypophosphatemic vitamin-D resistant rickets associated with epidermal nevus syndrome. A case report. Turk J Pediatr 1997; 39 (2) 247-251
• 16 Olivares JL, Ramos FJ, Carapeto FJ, Bueno M. Epidermal naevus syndrome and hypophosphataemic rickets: description of a patient with central nervous system anomalies and review of the literature. Eur J Pediatr 1999; 158 (2) 103-107
• 17 Yu TW, Tsau YK, Young C, Chiu HC, Shen YZ. Epidermal nevus syndrome with hypermelanosis and chronic hyponatremia. Pediatr Neurol 2000; 22 (2) 151-154
• 18 Mehregan AH, Pinkus H. Life history of organoid nevi special reference to nevus sebaceous of Jadassohn. Arch Derm 1965; 91: 574-588
• 19 Nour I, Abdel-Hady H, Nasef N, Shaaban AA. Linear nevus sebaceous syndrome in a neonate conceived by intracytoplasmic sperm injection. J Clin Neonatol 2012; 1 (3) 143-145
• 20 Feuerstein RC, Mims LC. Linear nevus sebaceus with convulsions and mental retardation. Am J Dis Child 1962; 104: 675-679
• 21 Zaremba J, Wislawski J, Bidzinski J, Kansy J, Sidor B. Jadassohn's naevus phakomatosis: I. A report of two cases. J Ment Defic Res 1978; 22 (2) 91-102
• 22 Clancy RR, Kurtz MB, Baker D, Sladky JT, Honig PJ, Younkin DP. Neurologic manifestations of the organoid nevus syndrome. Arch Neurol 1985; 42 (3) 236-240
• 23 Baker RS, Ross PA, Baumann RJ. Neurologic complications of the epidermal nevus syndrome. Arch Neurol 1987; 44 (2) 227-232
• 24 Pavone L, Curatolo P, Rizzo R , et al. Epidermal nevus syndrome: a neurologic variant with hemimegalencephaly, gyral malformation, mental retardation, seizures, and facial hemihypertrophy. Neurology 1991; 41 (2, Pt 1) 266-271
• 25 Grebe TA, Rimsza ME, Richter SF, Hansen RC, Hoyme HE. Further delineation of the epidermal nevus syndrome: two cases with new findings and literature review. Am J Med Genet 1993; 47 (1) 24-30
• 26 Happle R. Epidermal nevus syndromes. Semin Dermatol 1995; 14 (2) 111-121
• 27 Vidaurri-de la Cruz H, Tamayo-Sánchez L, Durán-McKinster C, de la Luz Orozco-Covarrubias M, Ruiz-Maldonado R. Epidermal nevus syndromes: clinical findings in 35 patients. Pediatr Dermatol 2004; 21 (4) 432-439
• 28 Sapp JC, Turner JT, van de Kamp JM, van Dijk FS, Lowry RB, Biesecker LG. Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients. Am J Med Genet A 2007; 143A (24) 2944-2958
• 29 Alomari AI. CLOVE(S) syndrome: expanding the acronym. Am J Med Genet A 2009; 149A (2) 294 , author reply 295
• 30 Lam J, Dohil MA, Eichenfield LF, Cunningham BB. SCALP syndrome: sebaceous nevus syndrome, CNS malformations, aplasia cutis congenita, limbal dermoid, and pigmented nevus (giant congenital melanocytic nevus) with neurocutaneous melanosis: a distinct syndromic entity. J Am Acad Dermatol 2008; 58 (5) 884-888
• 31 Flores-Sarnat L. Hemimegalencephaly: part 1. Genetic, clinical, and imaging aspects. J Child Neurol 2002; 17 (5) 373-384 , discussion 384
• 32 Flores-Sarnat L. Epidermal nevus syndrome. In: Dulac O, Lassonde M, Sarnat HB, eds. Pediatric Neurology. Handbook of Clinical Neurology. Vol. 111. 3rd series. Amsterdam: Elsevier; 2013: 349-368
• 33 Sulzberger MB. Obituary: Josef Jadassohn 1863 - 1936. An appreciation. Arch Derm Syphilol 1936; 33: 1063-1069
• 34 Sulzberger MB. Josef Jadassohn. A personal appreciation. Am J Dermatopathol 1985; 7 (1) 31-36
• 35 Weyers W. Josef Jadassohn—an appreciation on the occasion of his 150th birthday. Am J Dermatopathol 2013; 35 (7) 742-751
• 36 Jadassohn J. Bemerkungen zür Histologie der systematisierten Naevi und über “Talgdrüsen — Naevi”. Arch Dermatol Syph (Paris) 1895; 33: 355-394
• 37 Gerhardt C. Beobachtungen über neuropathisches Hautpapillom. Jahrb Kinderheilk 1871; 4: 270
• 38 Bögel G. Ueber das subconjunctival Lipom und eine Combination desselben mit Ichthyosis hystrix. Archiv Ophthalmol 1886; 32: 129-150
• 39 Blaschko A. Die Nervenverteilung in der Haut ihrer Beziehung zu den Erkrankungen der Haut. Wien: Wilhelm Braumuller; 1901
• 40 Robinson SS. Nevus sebaceous (Jadassohn). Arch Derm Syphilol 1932; 26: 663-670
• 41 Van Bogaert L. Les dysplasies neuroectodermiques. Rev Neurol 1935; 63: 353
• 42 Pack GT, Sunderland DA. Nevus unius lateris. Arch Surg 1941; 43: 341-372
• 43 Schimmelpenning GW. Klinischer Beitrag zur Symptomatologie der Phakomatosen. Fortschr Rontgenstr 1957; 87: 716-720
• 44 Besser FS. Linear sebaceous naevi with convulsions and mental retardation (Feuerstein-Mims' syndrome), vitamin-D-resistant rickets. Proc R Soc Med 1976; 69 (7) 518-520
• 45 Neumann LM, Scheer I, Kunze J, Stöver B. Cerebral manifestations, hemihypertrophy and lymphoedema of one leg in a child with epidermal nevus syndrome (Schimmelpenning-Feuerstein-Mims). Pediatr Radiol 2003; 33 (9) 637-640
• 46 Rijntjes-Jacobs EG, Lopriore E, Steggerda SJ, Kant SG, Walther FJ. Discordance for Schimmelpenning-Feuerstein-Mims syndrome in monochorionic twins supports the concept of a postzygotic mutation. Am J Med Genet A 2010; 152A (11) 2816-2819
• 47 Schimmelpenning GW. Long-term observation of a case of organoid naevus phakomatosis (Schimmelpenning-Feuerstein-Mims syndrome) [in German]. Rofo 1983; 139 (1) 63-67
• 48 Warnke PH, Hauschild A, Schimmelpenning GW, Terheyden H, Sherry E, Springer IN. The sebaceous nevus as part of the Schimmelpenning-Feuerstein-Mims Syndrome—an obvious phacomatosis first documented in 1927. J Cutan Pathol 2003; 30 (7) 470-472
• 49 Happle R. Gustav Schimmelpenning and the syndrome bearing his name. Dermatology 2004; 209 (2) 84-87
• 50 Greene AK, Rogers GF, Mulliken JB. Schimmelpenning syndrome: an association with vascular anomalies. Cleft Palate Craniofac J 2007; 44 (2) 208-215
• 51 Happle R. The group of epidermal nevus syndromes Part II. Less well defined phenotypes. J Am Acad Dermatol 2010; 63 (1) 25-30 , quiz 31–32
• 52 Morrow PA. Two cases of linear naevus with remarks on its nature and nomenclature. NY Med J 1898; 67: 1
• 53 Curth HO, Warburton D. The genetics of incontinentia pigmenti. Arch Dermatol 1965; 2: 229-351
• 54 Lenz W. On the genetics of incontinentia pigmenti [in German]. Ann Paediatr 1961; 196: 149-165
• 55 Happle R. Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol 1987; 16 (4) 899-906
• 56 Moss C, Larkins S, Stacey M, Blight A, Farndon PA, Davison EV. Epidermal mosaicism and Blaschko's lines. J Med Genet 1993; 30 (9) 752-755
• 57 Sarnat HB, Flores-Sarnat L. Neurocutaneous syndromes as embryonic neurocristopathies. J Pediatr Epilepsy 2016; 5 (2) 70-81
• 58 Sarnat HB, Flores-Sarnat L. Embryology of the neural crest: its inductive role in the neurocutaneous syndromes. J Child Neurol 2005; 20 (8) 637-643
• 59 Jackson R. The lines of Blaschko: a review and reconsideration: Observations of the cause of certain unusual linear conditions of the skin. Br J Dermatol 1976; 95 (4) 349-360
• 60 Stern C. Somatic crossing-over and segregation in Drosophila melanogaster. Genetics 1936; 21 (6) 625-730
• 61 Hafner C, van Oers JM, Vogt T , et al. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest 2006; 116 (8) 2201-2207
• 62 Hafner C, Toll A, Gantner S , et al. Keratinocytic epidermal nevi are associated with mosaic RAS mutations. J Med Genet 2012; 49 (4) 249-253
• 63 Ousager LB, Bygum A, Hafner C. Identification of a novel S249C FGFR3 mutation in a keratinocytic epidermal naevus syndrome. Br J Dermatol 2012; 167 (1) 202-204
• 64 Groesser L, Herschberger E, Ruetten A , et al. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome. Nat Genet 2012; 44 (7) 783-787
• 65 Levinsohn JL, Tian LC, Boyden LM , et al. Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus. J Invest Dermatol 2013; 133 (3) 827-830
• 66 Sun BK, Saggini A, Sarin KY , et al. Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome. J Invest Dermatol 2013; 133 (3) 824-827
• 67 Lee JH, Huynh M, Silhavy JL , et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 2012; 44 (8) 941-945
• 68 Poduri A, Evrony GD, Cai X , et al. Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 2012; 74 (1) 41-48
• 69 Poduri A, Evrony GD, Cai X, Walsh CA. Somatic mutation, genomic variation, and neurological disease. Science 2013; 341 (6141) 1237758
• 70 Lindhurst MJ, Sapp JC, Teer JK , et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 2011; 365 (7) 611-619
• 71 Tanaka T, Ida N, Shimoda H, Waki C, Slamon DJ, Cline MJ. Organ specific expression of ras oncoproteins during growth and development of the rat. Mol Cell Biochem 1986; 70 (1) 97-104
• 72 Goodsell DS. The molecular perspective: the ras oncogene. Oncologist 1999; 4 (3) 263-264
• 73 Castellano E, Santos E. Functional specificity of ras isoforms: so similar but so different. Genes Cancer 2011; 2 (3) 216-231
• 74 Fiorucci G, Hall A. All three human ras genes are expressed in a wide range of tissues. Biochim Biophys Acta 1988; 950 (1) 81-83
• 75 Shih F, Yip S, McDonald PJ, Chudley AE, Del Bigio MR. Oncogenic codon 13 NRAS mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis. Acta Neuropathol Commun 2014; 2: 140
• 76 Groesser L, Herschberger E, Sagrera A , et al. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell. J Invest Dermatol 2013; 133 (8) 1998-2003
• 77 Luo S, Tsao H. Epidermal, sebaceous, and melanocytic nevoid proliferations are spectrums of mosaic RASopathies. J Invest Dermatol 2014; 134 (10) 2493-2496
• 78 Hall BK. The Neural Crest and Neural Crest Cells in Vertebrate Development and Evolution. New York, NY: Springer; 2009
• 79 Kirby ML, Gale TF, Stewart DE. Neural crest cells contribute to normal aorticopulmonary septation. Science 1983; 220 (4601) 1059-1061
• 80 Roguin A. Wilhelm His Jr. (1863-1934)—the man behind the bundle. Heart Rhythm 2006; 3 (4) 480-483
• 81 Snider P, Olaopa M, Firulli AB, Conway SJ. Cardiovascular development and the colonizing cardiac neural crest lineage. ScientificWorldJournal 2007; 7: 1090-1113
• 82 Etchevers HC, Vincent C, Le Douarin NM, Couly GF. The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development 2001; 128 (7) 1059-1068
• 83 Le Douarin NM, Couly G, Creuzet SE. The neural crest is a powerful regulator of pre-otic brain development. Dev Biol 2012; 366 (1) 74-82
• 84 Tidyman WE, Rauen KA. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev 2009; 19 (3) 230-236
• 85 Canyigit M, Oguz KK. Epidermal nevus syndrome with internal carotid artery occlusion and intracranial and orbital lipomas. AJNR Am J Neuroradiol 2006; 27 (7) 1559-1561
• 86 Alfonso I, Howard C, Lopez PF, Palomino JA, Gonzalez CE. Linear nevus sebaceous syndrome. A review. J Clin Neuroophthalmol 1987; 7 (3) 170-177
• 87 Duncan JL, Golabi M, Fredrick DR , et al. Complex limbal choristomas in linear nevus sebaceous syndrome. Ophthalmology 1998; 105 (8) 1459-1465
• 88 Singal A, Dhaliwal U, Bhattacharya SN, Rohatgi J, Singh N. Complex ocular choristomas in linear nevus sebaceus syndrome: a report of two cases. J Dermatol 2001; 28 (5) 259-264
• 89 Lall K. Teratoma of conjunctiva. Acta Ophthalmol (Copenh) 1962; 40: 555-558
• 90 Chen CC, Lien SH, Hsu ML , et al. Linear nevus sebaceous syndrome. J Med Sci 2006; 26: 77-82
• 91 Tripp JH, Joseph MC, Reay HA. A new neurocutaneous syndrome (skin, eye, brain and heart syndrome). Proc R Soc Med 1971; 64 (1) 23-24
• 92 Maclellan RA, Luks VL, Vivero MP , et al. PIK3CA activating mutations in facial infiltrating lipomatosis. Plast Reconstr Surg 2014; 133 (1) 12e-19e
• 93 Vles JSH, Degraeuwe P, De Cock P, Casaer P. Neuroradiological findings in Jadassohn nevus phakomatosis: a report of four cases. Eur J Pediatr 1985; 144 (3) 290-294
• 94 el-Shanti H, Bell WE, Waziri MH. Epidermal nevus syndrome: subgroup with neuronal migration defects. J Child Neurol 1992; 7 (1) 29-34
• 95 Di Rocco F, Novegno F, Tamburrini G, Iannelli A. Hemimegalencephaly involving the cerebellum. Pediatr Neurosurg 2001; 35 (5) 274-276
• 96 Donati L, Candiani P, Grappolini S, Klinger M, Signorini M. Congenital infiltrating lipomatosis of the face related to cytomegalovirus infection. Br J Plast Surg 1990; 43 (1) 124-126
• 97 Unal O, Cirak B, Bekerecioglu M, Kutluhan A, Ugraş S, Tali T. Congenital infiltrating lipomatosis of the face with cerebral abnormalities. Eur Radiol 2000; 10 (10) 1610-1613
• 98 Aydíngöz U, Emir S, Karlí-Oğuz K, Köse G, Büyükpamukçu M. Congenital infiltrating lipomatosis of the face with ipsilateral hemimegalencephaly. Pediatr Radiol 2002; 32 (2) 106-109
• 99 Slavin SA, Baker DC, McCarthy JG, Mufarrij A. Congenital infiltrating lipomatosis of the face: clinicopathologic evaluation and treatment. Plast Reconstr Surg 1983; 72 (2) 158-164
• 100 Pollock RA, Newman MH, Burdi AR, Condit DP. Congenital hemifacial hyperplasia: an embryologic hypothesis and case report. Cleft Palate J 1985; 22 (3) 173-184
• 101 Hafner C, López-Knowles E, Luis NM , et al. Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern. Proc Natl Acad Sci U S A 2007; 104 (33) 13450-13454
• 102 Diaz JH. Perioperative management of infants with the linear naevus sebaceous syndrome of Jadassohn: a report of two cases. Paediatr Anaesth 2000; 10 (6) 669-673
• 103 Trapp LD, Lee C, Troutman KC, Simon JE. Anesthetic management of the pediatric patient with multiple congenital anomalies including severe hemifacial hypertrophy. Anesth Prog 1981; 28 (6) 162-166
• 104 Sarnat HB, Philippart M, Flores-Sarnat L, Wei X-C. Timing in neural maturation: arrest, delay, precociousness, and temporal determination of malformations. Pediatr Neurol 2015; 52 (5) 473-486
• 105 Sakuta R, Aikawa H, Takashima S, Ryo S. Epidermal nevus syndrome with hemimegalencephaly: neuropathological study. Brain Dev 1991; 13 (4) 260-265
• 106 Bosemani T, Boltshauser E, Staudt M , et al. Hemimegalencephaly: involvement of cranial nerves and intracranial vessels. Neuropediatrics 2013; 44: 1031 (Abstract)
• 107 Mollica F, Pavone L, Nuciforo G. Linear sebaceous nevus syndrome in a newborn. Am J Dis Child 1974; 128 (6) 868-871
• 108 Chalhub EG, Volpe JJ, Gado MH. Linear nevus sebaceous syndrome associated with porencephaly and nonfunctioning major cerebral venous sinuses. Neurology 1975; 25 (9) 857-860
• 109 Brihaye J, Brihaye-van Geertruyden M, Retif J, Mercier AM. Late occurrence of additional ocular and intracranial pathologies in the linear naevus sebaceous (Feuerstein-Mims) syndrome. Acta Neurochir (Wien) 1988; 92 (1–4) 132-137
• 110 Aizawa K, Nakamura T, Ohyama Y , et al. Renal artery stenosis associated with epidermal nevus syndrome. Nephron 2000; 84 (1) 67-70
• 111 Mullaney PB, Weatherhead RG. Epidermal nevus syndrome associated with a complex choristoma and a bilateral choroidal osteoma. Arch Ophthalmol 1996; 114 (10) 1292-1293
• 112 Booth TN, Rollins NK. MR imaging of the spine in epidermal nevus syndrome. AJNR Am J Neuroradiol 2002; 23 (9) 1607-1610
• 113 Ozkiriş A, Evereklioglu C, Kula M, Somdaş M, Erkiliç K, Coşkun A. Tc-99m HMPAO brain SPECT in linear nevus sebaceous syndrome. Ann Nucl Med 2003; 17 (8) 703-706
• 114 Dobyns WB, Garg BP. Vascular abnormalities in epidermal nevus syndrome. Neurology 1991; 41 (2, Pt 1) 276-278
• 115 Kwa VI, Smitt JH, Verbeeten BW, Barth PG. Epidermal nevus syndrome with isolated enlargement of one temporal lobe: a case report. Brain Dev 1995; 17 (2) 122-125
• 116 Cross JH. Neurocutaneous syndromes and epilepsy-issues in diagnosis and management. Epilepsia 2005; 46 (Suppl 10): 17-23
• 117 Gurecki PJ, Holden KR, Sahn EE, Dyer DS, Cure JK. Developmental neural abnormalities and seizures in epidermal nevus syndrome. Dev Med Child Neurol 1996; 38 (8) 716-723
• 118 Pujol RM, Tuneu A, De Moragas JM , et al. Síndrome del nevus sebáceo lineal. Med Cut I L A 1987; 15: 280-284
• 119 Loddenkemper T, Alexopoulos AV, Kotagal P , et al. Epilepsy surgery in epidermal nevus syndrome variant with hemimegalencephaly and intractable seizures. J Neurol 2008; 255 (11) 1829-1831
• 120 Dodge NN, Dobyns WB. Agenesis of the corpus callosum and Dandy-Walker malformation associated with hemimegalencephaly in the sebaceous nevus syndrome. Am J Med Genet 1995; 56 (2) 147-150
• 121 Brodsky MC, Kincannon JM, Nelson-Adesokan P, Brown HH. Oculocerebral dysgenesis in the linear nevus sebaceous syndrome. Ophthalmology 1997; 104 (3) 497-503
• 122 Vigevano F, Aicardi J, Lini M, Pasquinelli A. La sindrome del nevo sebaceo lineare: Presentazione di una casistica multicentrica. Boll Lega Ital Epil 1984; 45/46: 59-63
• 123 Mimouni F, Han BK, Barnes L , et al. Multiple hamartomas associated with intracranial malformation. Pediatr Dermatol 1986; 3 (3) 219-225
• 124 Kinsler VA, Thomas AC, Ishida M , et al. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol 2013; 133 (9) 2229-2236
• 125 Salgado CM, Basu D, Nikiforova M , et al. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi. Pediatr Dev Pathol 2015; 18 (1) 1-9
• 126 Cohen Jr MM. Proteus syndrome: an update. Am J Med Genet C Semin Med Genet 2005; 137C: 38-52
• 127 Biesecker L. The challenges of Proteus syndrome: diagnosis and management. Eur J Hum Genet 2006; 14 (11) 1151-1157
• 128 Eve FS. Congenital hypertrophy of the foot and leg, especially of the skin and subcutaneous tissue of the sole. Pathol Trans (London) 1983; 34: 298-304
• 129 Finlayson J. On the case of a child affected with congenital unilateral hypertrophy and patches of cutaneous congestion. Glasg Med J 1884; 22: 327-337
• 130 Webster JHD. A case of unilateral cerebral hyperplasia with co-existent “acromegaly” of the feet and a slight degree of unilateral gigantism. J Path Bact 1907; 12: 306-309
• 131 Turner JT, Cohen Jr MM, Biesecker LG. Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases. Am J Med Genet A 2004; 130A (2) 111-122
• 132 Rizzo R, Pavone L, Sorge G, Parano E, Baraitser M. Proteus syndrome: report of a case with severe brain impairment and fatal course. J Med Genet 1990; 27 (6) 399-402
• 133 Sarnat HB, Diadori P, Trevenen CL. Myopathy of the Proteus syndrome: hypothesis of muscular dysgenesis. Neuromuscul Disord 1993; 3 (4) 293-301
• 134 Dietrich RB, Glidden DE, Roth GM, Martin RA, Demo DS. The Proteus syndrome: CNS manifestations. AJNR Am J Neuroradiol 1998; 19 (5) 987-990
• 135 DeLone DR, Brown WD, Gentry LR. Proteus syndrome: craniofacial and cerebral MRI. Neuroradiology 1999; 41 (11) 840-843
• 136 Ahmetoğlu A, Işik Y, Aynaci O, Bahadir S, Aynaci FM. Proteus syndrome associated with liver involvement: case report. Genet Couns 2003; 14: 221-226
• 137 Demir MK. Case 131: Proteus syndrome. Radiology 2008; 246 (3) 974-979
• 138 Jackson PE, Huang YT, Fiumara F, Long G. Ictal SPECT with MRI fusion localizing a seizure focus in child with hemimegalencephaly and proteus syndrome. Clin Nucl Med 2010; 35 (8) 637-639
• 139 Kaduthodil MJ, Prasad DS, Lowe AS, Punekar AS, Yeung S, Kay CL. Imaging manifestations in Proteus syndrome: an unusual multisystem developmental disorder. Br J Radiol 2012; 85 (1017) e793-e799
• 140 Kurek KC, Luks VL, Ayturk UM , et al. Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet 2012; 90 (6) 1108-1115
• 141 Fernandez-Pineda I, Fajardo M, Chaudry G, Alomari AI. Perinatal clinical and imaging features of CLOVES syndrome. Pediatr Radiol 2010; 40 (8) 1436-1439
• 142 Gucev ZS, Tasic V, Jancevska A , et al. Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) syndrome: CNS malformations and seizures may be a component of this disorder. Am J Med Genet A 2008; 146A (20) 2688-2690
• 143 Di Rocco C, Battaglia D, Pietrini D, Piastra M, Massimi L. Hemimegalencephaly: clinical implications and surgical treatment. Childs Nerv Syst 2006; 22 (8) 852-866
• 144 Gross H, Uiberrak B. Klinisch-anatomische Befunde bei Hemimegalencephalie; über die Stellung der cerebralen Hyperplasie und des örtlichen Riesenwuchses innerhalb der Phakomatosen [in German]. Virchows Arch 1955; 327 (5) 577-589
• 145 Ronen GM, Meaney B, Dan B, Zimprich F, Stögmann W, Neugebauer W. From eugenic euthanasia to habilitation of “disabled” children: Andreas Rett's contribution. J Child Neurol 2009; 24 (1) 115-127
• 146 Dean JCS, Cole GF, Appleton RE, Burn J, Roberts SA, Donnai D. Cranial hemihypertrophy and neurodevelopmental prognosis. J Med Genet 1990; 27 (3) 160-164
• 147 Trounce JQ, Rutter N, Mellor DH. Hemimegalencephaly: diagnosis and treatment. Dev Med Child Neurol 1991; 33 (3) 261-266
• 148 Cavenagh EC, Hart BL, Rose D. Association of linear sebaceous nevus syndrome and unilateral megalencephaly. AJNR Am J Neuroradiol 1993; 14 (2) 405-408
• 149 Barkovich AJ, Chuang SH. Unilateral megalencephaly: correlation of MR imaging and pathologic characteristics. AJNR Am J Neuroradiol 1990; 11 (3) 523-531
• 150 Sarwar M, Schafer ME. Brain malformations in linear nevus sebaceous syndrome: an MR study. J Comput Assist Tomogr 1988; 12 (2) 338-340
• 151 Carter BS, Hurst DL. Magnetic resonance imaging of the brain in the linear sebaceous nevus syndrome. J Child Neurol 1990; 5 (1) 68-69
• 152 Zhang W, Simos PG, Ishibashi H , et al. Neuroimaging features of epidermal nevus syndrome. AJNR Am J Neuroradiol 2003; 24 (7) 1468-1470
• 153 Maher CO, Cohen-Gadol AA, Raffel C. Cortical resection for epilepsy in children with linear sebaceous nevus syndrome. Pediatr Neurosurg 2003; 39 (3) 129-135
• 154 Lien SH, Hsu ML, Yuh YS , et al. Prenatal three dimensional ultrasound detection of linear nevus sebaceous syndrome. Arch Dis Child Fetal Neonatal Ed 2005; 90 (4) F315
• 155 Neis AE, Johansen KL, Harms RW, Watson WJ, Brost BC. Sonographic characteristics of linear nevus sebaceous sequence. Ultrasound Obstet Gynecol 2006; 27 (3) 323-324
• 156 Berg JM, Crome L. A possible case of atypical tuberous sclerosis. J Ment Defic Res 1960; 4: 24-31
• 157 Merks JH, de Vries LS, Zhou XP , et al. PTEN hamartoma tumour syndrome: variability of an entity. J Med Genet 2003; 40 (10) e111
• 158 Sarnat H, Flores-Sarnat L, Crino P, Hader W, Bello-Espinosa L. Hemimegalencephaly: foetal tauopathy with mTOR hyperactivation and neuronal lipidosis. Folia Neuropathol 2012; 50 (4) 330-345
• 159 Flores-Sarnat L, Sarnat HB, Dávila-Gutiérrez G, Alvarez A. Hemimegalencephaly: part 2. Neuropathology suggests a disorder of cellular lineage. J Child Neurol 2003; 18 (11) 776-785
• 160 Sarnat HB, Flores-Sarnat L. Infantile tauopathies: Hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma. Brain Dev 2015; 37 (6) 553-562
• 161 Boer K, Troost D, Spliet WGM, Redeker S, Crino PB, Aronica E. A neuropathological study of two autopsy cases of syndromic hemimegalencephaly. Neuropathol Appl Neurobiol 2007; 33 (4) 455-470
• 162 Crino PB. Molecular pathogenesis of focal cortical dysplasia and hemimegalencephaly. J Child Neurol 2005; 20 (4) 330-336
• 163 Okumura A, Lee T, Ikeno M , et al. A severe form of epidermal nevus syndrome associated with brainstem and cerebellar malformations and neonatal medulloblastoma. Brain Dev 2012; 34 (10) 881-885
• 164 Vigevano F, Bertini E, Boldrini R , et al. Hemimegalencephaly and intractable epilepsy: benefits of hemispherectomy. Epilepsia 1989; 30 (6) 833-843
• 165 Demaerel P, Wilms G, Casaer P. More association of linear sebaceous nevus syndrome and unilateral megalencephaly. AJNR Am J Neuroradiol 1994; 15 (1) 196-197
• 166 Wakabayashi C, Maehara T, Shimamura T , et al. Unilateral megalencephaly in linear nevus sebaceous syndrome: a neuroradiological case report. Radiat Med 1997; 15 (1) 65-69
• 167 Allison MA, Dunn CL, Pedersen RC. What syndrome is this? Epidermal nevus syndrome: a neurologic variant with hemimegalencephaly, facial hemihypertrophy and gyral malformation. Pediatr Dermatol 1998; 15 (1) 59-61
• 168 van de Warrenburg BPC, van Gulik S, Renier WO, Lammens M, Doelman JC. The linear naevus sebaceus syndrome. Clin Neurol Neurosurg 1998; 100 (2) 126-132
• 169 Herman TE, Siegel MJ. Hemimegalencephaly and linear nevus sebaceous syndrome. J Perinatol 2001; 21 (5) 336-338
• 170 Paladin F, Chiron C, Dulac O, Plouin P, Ponsot G. Electroencephalographic aspects of hemimegalencephaly. Dev Med Child Neurol 1989; 31 (3) 377-383
• 171 Hager BC, Dyme IZ, Guertin SR, Tyler RJ, Tryciecky EW, Fratkin JD. Linear nevus sebaceous syndrome: megalencephaly and heterotopic gray matter. Pediatr Neurol 1991; 7 (1) 45-49
• 172 Kurokawa T, Sasaki K, Hanai T, Goya N, Komaki S. Linear nevus sebaceus syndrome. Report of a case with Lennox-Gastaut syndrome following infantile spasms. Arch Neurol 1981; 38 (6) 375-377
• 173 Ohtsuka Y, Ohno S, Oka E. Electroclinical characteristics of hemimegalencephaly. Pediatr Neurol 1999; 20 (5) 390-393
• 174 Bonioli EV, Bertola A, Di Stefano A, Bellini C. Sebaceous nevus syndrome: report of two cases. Pediatr Neurol 1997; 17 (1) 77-79
• 175 Sasaki M, Matsuda H, Arai Y, Hashimoto T. Startle-induced epilepsy in a patient with epidermal nevus syndrome. Pediatr Neurol 1998; 18 (4) 346-349
• 176 Bianchine JW. The nevus sebaceous of Jadassohn. A neurocutaneous syndrome and a potentially premalignant lesion. Am J Dis Child 1970; 120 (3) 223-228
• 177 Flores-Sarnat L. Hemimegalencephaly syndrome. In: Sarnat HB, Curatolo P, eds. Handbook of Clinical Neurology. Vol. 87: Malformations of the Nervous System. Edinburgh: Elsevier; 2008: 162
• 178 Go CY, Mackay MT, Weiss SK , et al; Child Neurology Society; American Academy of Neurology; Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Evidence-based guideline update: medical treatment of infantile spasms. Neurology 2012; 78 (24) 1974-1980
• 179 Lawlor KM, Devlin AM. Levetiracetam in the treatment of infantile spasms. Eur J Paediatr Neurol 2005; 9 (1) 19-22
• 180 Kossoff EH, Zupec-Kania BA, Rho JM. Ketogenic diets: an update for child neurologists. J Child Neurol 2009; 24: 979-88
• 181 Vigevano F, di Rocco C. Effectiveness of hemispherectomy in hemimegalencephaly with intractable seizures. Neuropediatrics 1990; 21: 222-223
• 182 Humbertclaude VT, Coubes PA, Robain O , et al. Early hemispherectomy in a case of hemimegalencephaly. Pediatr Neurosurg 1997; 27: 268-271
• 183 Soufflet C, Bulteau C, Delalande O , et al. The nonmalformed hemisphere is secondarily impaired in young Children with Hemimegalencephaly: A Pre- and Postsurgery Study with SPECT and EEG. Epilepsia 2004; 45: 1375-1382
• 184 Winston KR, Kang J, Laoprasert P , et al. Hemispherectomy in a premature neonate with linear sebaceous nevus syndrome. Pediatr Neurosurg 2008; 44: 159-164
• 185 Chen Y, Wang B-C, Xiao Y. PI3K: A potential therapeutic target for cancer. J Cell Physiol 2012; 227: 2818-2821
• 186 Marsh DJ, Trahair TN, Martin JL , et al. Rapamycin treatment for a child with germline PTEN mutation. Nat Clin Pract Oncol 2008; 5 (6) 357-361